Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-05 HAYDEN DONALD J JR Director Exercise or conversion · Stock Option (Right to Buy) −14,900 189,100
2018-06-01 HAYDEN DONALD J JR Director Exercise or conversion +100 $0.85 $85 100
2018-06-01 HAYDEN DONALD J JR Director Sale −100 $55.00 $6K 0
2018-06-01 HAYDEN DONALD J JR Director Exercise or conversion · Stock Option (Right to Buy) −100 204,000
2018-05-25 KARABELAS ARGERIS N Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2018-05-25 Tasse Daniel Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2018-05-25 STUMP DAVID C Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2018-05-25 HAYDEN DONALD J JR Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2018-05-25 Fox Allan M. Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2018-05-25 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2018-05-25 Abdun-Nabi Daniel Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2018-05-25 Glucksmann Alexandra Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2018-05-21 Mills Kenneth T. President and CEO Sale −6,799 $46.56 $317K 211,731
2018-05-21 Mills Kenneth T. President and CEO Sale −1,800 $47.88 $86K 209,931
2018-05-21 Mills Kenneth T. President and CEO Sale −1,401 $48.39 $68K 208,530
2018-05-15 Vasista Vittal Chief Financial Officer Sale −1,100 $49.21 $54K 151,183
2018-05-15 Vasista Vittal Chief Financial Officer Sale −3,945 $49.93 $197K 147,238
2018-05-15 Vasista Vittal Chief Financial Officer Sale −2,455 $50.76 $125K 144,783
2018-05-15 HAYDEN DONALD J JR Director Exercise or conversion +9,847 $0.85 $8K 9,847
2018-05-15 HAYDEN DONALD J JR Director Sale −9,847 $50.06 $493K 0

Page 41 of 43 · 852 trades